Participants, n (%) | Baseline (n = 707) | Follow-up (n = 268) |
---|---|---|
Gender | ||
Male | 500 (71) | 208 (78) |
Female | 207 (29) | 60 (22) |
Age, n (%) | ||
18–29 | 83 (12) | 25 (9) |
30–39 | 203 (29) | 71 (26) |
40–49 | 217 (31) | 87 (32) |
50–59 | 161 (23) | 71 (26) |
≥ 60 | 43 (6) | 14 (5) |
Mean (SD) | 43 (11) | 45 (10) |
Highest education completed, n (%) | ||
Not completed lower secondary school | 41 (6) | 15 (6) |
Completed lower secondary school (9 years) | 309 (44) | 128 (48) |
Completed upper secondary school (12 years) | 285 (40) | 99 (37) |
Completed under or postgraduate studies (≥ 12 years) | 72 (10) | 26 (10) |
Current living conditions, n (%) | ||
Stable (owned, rented or incarcerated) | 619 (88) | 242 (90) |
Unstable (homeless, with family/friends) | 88 (12) | 26 (10) |
Worrying debt situation | 292 (41) | 116 (43) |
Participants enrolled in OAT, n (%) | 590 (83) | 248 (93) |
OAT medications of those; n (%) | ||
- Methadone | 224 (38) | 110 (44) |
- Buprenorphine-based | 357 (61) | 134 (54) |
OAT treatment ratio*, mean (SD) | 0.9 (0.4) | 0.9 (0.3) |
Injecting and frequent substance use past 12 months, n (%) | ||
Injected at least once | 352 (54) | 142 (53) |
Alcohol | 165 (25) | 67 (25) |
Cannabis | 329 (50) | 145 (55) |
Stimulants (amphetamine/methamphetamine/cocaine) | 183 (28) | 73 (27) |
Opioids (other than OAT) | 103 (16) | 29 (11) |
Benzodiazepines | 248 (38) | 104 (39) |